InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
45%
T+90 mean return
-5.2%
Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Humphries William D., Director. Officer active across 4 companies, notably STRATA Skin Sciences, Inc.. In total, 13 reports have been logged. Split: 2 buys · 0 sell. Total volume traded: €48k. History available since 20 July 2021. The latest transaction was filed on 22 September 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations13 total
11,580 sharesCommon StockSEC:0001674278-26-000002:0
4,660 sharesCommon StockSEC:0001415889-24-015364:0
22,727 shares@ US$0.4058.7% of flowCommon StockSEC:0001209191-23-050381:0
36,408 shares@ US$1.0341.9% of flowSSKN Common StockSEC:0001051514-23-000029:0
4,507 sharesCommon StockSEC:0001209191-23-034477:0
2,538 sharesCommon StockSEC:0001169245-23-000031:0
3,356 sharesCommon StockSEC:0001209191-22-034585:0
16,950 shares@ US$1.73360.36% mcap55.7% of flowSSKN Common StockSEC:0001051514-22-000035:0
Ideal exit: 20 Dec 2022 (T+270)
14,783 shares@ US$1.5820.29% mcap44.3% of flowSSKN Common StockSEC:0001051514-22-000033:0
Ideal exit: 19 Dec 2022 (T+270)
22,727 shares@ US$0.150.0041% mcap50.0% of flowCommon StockSEC:0001209191-22-002893:0
22,727 shares@ US$0.1520.7% of flowCommon StockSEC:0001209191-22-002893
20,000 shares0SSKN Common StockSEC:0001051514-21-000034
20,000 shares0SSKN Common StockSEC:0001051514-21-000034:0
13 of 13 declarations
About Humphries William D.
William D. Humphries serves as a Director at Strata Skin Sciences, Inc., Clearside Biomedical, Inc., and Aclaris Therapeutics, Inc. In these roles, he participates in the governance and strategy of the companies, bringing his expertise in the life sciences field. William D. Humphries is committed to ensuring regulatory compliance and supporting the growth of these companies through informed and strategic decision-making.
